UnitedHealth Group Shows Stability in Medicare Advantage Ratings and Earnings Guidance
UnitedHealth Group maintains strong 2026 Medicare Advantage Stars ratings and reaffirms 2025 earnings guidance, signaling stability amid market challenges.
UnitedHealth Group maintains strong 2026 Medicare Advantage Stars ratings and reaffirms 2025 earnings guidance, signaling stability amid market challenges.
Health Care Service Corporation expands its Medicare Advantage coverage to 30 states and DC, enhancing its national presence with diverse plan options for 2026.
FTC cautions healthcare employers on noncompetes. Rising physician unionization, Medicare Plan Finder updates, Kaiser-Renown joint venture, AI tools, FDA drug approvals, and robotic intubation device mark key healthcare industry trends in 2025.
As Medicare open enrollment begins, scammers increase efforts to steal seniors' personal and Medicare information through fraudulent calls. Learn how to detect and prevent Medicare-related fraud effectively.
Projected 2.8% Social Security COLA for 2026 offsets by rising Medicare Part B and D premiums amid increasing senior poverty rates. Key inflation and policy insights.
CMS's 2026 Medicare payment proposals aim to rebalance reimbursements in favor of primary care and outpatient clinics, reduce hospital-owned clinic premiums, and introduce site-neutral payments to improve Medicare value and primary care sustainability.
Healthcare industry addresses physician shortages and budget pressures by integrating Advanced Practice Providers and adapting nurse leader engagement strategies in social media to improve workforce management.
U.S. stock markets were flat after weak job growth data raised rate cut odds. UnitedHealth forecasts strong Medicare Advantage enrollment while AI firms Nebius and CoreWeave post gains. Copper miner merger creates industry shift.
SelectQuote under DOJ investigation for Medicare Advantage sales practices faces securities class-action lawsuit amid stock decline. Legal and regulatory insights.
UnitedHealth Group's stock price rises on stable Medicare Advantage ratings and 2025 earnings guidance despite regulatory scrutiny and mixed insider trading activity.